Table 4.
Disease-specific survival and overall survival.
| Disease-specific survival |
Overall survival |
|||||
|---|---|---|---|---|---|---|
| Univariate |
Multivariate |
Univariate |
Multivariate |
|||
| p-Value | p-Value | HR (95%CI) | p-Value | p-Value | HR (95%CI) | |
| Size ≥3 cm | 0.015 | 0.618 | 0.024 | 0.845 | ||
| No. of tumors ≥2 | 0.531 | 0.842 | 0.645 | 0.997 | ||
| High grade tumor | 0.70 | 0.098 | 0.118 | 0.180 | ||
| Hydronephrosis | 0.002 | 0.961 | 0.003 | 0.872 | ||
| Anemia | 0.008 | 0.097 | 0.001 | 0.010 | 2.570 (1.250–5.286) | |
| NLR ≥2.7 | <0.001 | 0.017 | 2.677 (1.193–6.009) | <0.001 | 0.008 | 2.850 (1.322–6.147) |
| T3/4 disease (extravesical) | <0.001 | 0.058 | 2.013 (0.976–4.152) | <0.001 | 0.159 | |
| LN involvement | <0.001 | 0.007 | 2.641 (1.303–5.356) | <0.001 | 0.005 | 2.648 (1.348–5.201) |
CI, confidence interval; LN, lymph node; NLR, neutrophil-to-lymphocyte ratio.